Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Nebula Research & Development LLC

Nebula Research & Development LLC cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 76.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,360 shares of the pharmacy operator’s stock after selling 35,989 shares during the period. Nebula Research & Development LLC’s holdings in Walgreens Boots Alliance were worth $106,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of WBA. Virtu Financial LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter valued at about $208,000. Wilmington Savings Fund Society FSB purchased a new position in Walgreens Boots Alliance during the 3rd quarter worth approximately $92,000. Franklin Resources Inc. lifted its stake in Walgreens Boots Alliance by 54.4% during the 3rd quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator’s stock valued at $2,893,000 after acquiring an additional 113,242 shares during the period. B. Riley Wealth Advisors Inc. boosted its holdings in shares of Walgreens Boots Alliance by 145.0% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 51,832 shares of the pharmacy operator’s stock valued at $456,000 after acquiring an additional 30,675 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Walgreens Boots Alliance by 253.0% in the fourth quarter. GAMMA Investing LLC now owns 29,069 shares of the pharmacy operator’s stock worth $271,000 after acquiring an additional 20,835 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Finally, StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a report on Sunday, April 27th. They set a “hold” rating on the stock. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Up 0.5 %

WBA stock opened at $10.98 on Friday. The stock has a market capitalization of $9.49 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83. The firm has a 50-day simple moving average of $10.97 and a 200-day simple moving average of $10.26. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the prior year, the company earned $1.20 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Chairman Stefano Pessina bought 832,258 shares of Walgreens Boots Alliance stock in a transaction on Sunday, April 27th. The shares were bought at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. This trade represents a 0.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.